Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By activating these receptors, Retatrutide suppresses appetite, {promotesenergy expenditure, and ultimately results in significant slimming. W